NMO-lgG and Devic's neuromyelitis optica: A French experience

Multiple Sclerosis

Volumn 14, Issue 4, 2008, Pages 440-445

  Marignier, Romain ^a,b,c   Sèze, Jérôme ^d   Vukusic, Sandra ^a,b,c   Durand Dubief, Françoise ^a,c   Zéphir, Hélène ^e   Vermersch, Patrick ^e   Cabre, Philippe ^f   Cavillon, Gaëlle ^b   Honnorat, Jérôme ^b,c   Confavreux, Christian ^a,b,c  

^a HOSPICES CIVILS DE LYON   (France)

^b INSERM   (France)

^c UNIVERSITÉ DE LYON   (France)

^d HÔPITAL CIVIL   (France)

^e LILLE UNIVERSITY HOSPITAL   (France)

^f CENTRE HOSPITALIER UNIVERSITAIRE DE FORT DE FRANCE   (France)

Author keywords

Devic's disease; Neuromyelitis optica; NMO IgG; Transverse myelitis

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN G ANTIBODY; BIOLOGICAL MARKER; IMMUNOGLOBULIN G;

ADOLESCENT; ADULT; ANIMAL TISSUE; ARTICLE; CEREBELLUM; CONTROLLED STUDY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FEMALE; FRANCE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IDIOPATHIC DISEASE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MESENCEPHALON; MYELITIS; MYELOOPTIC NEUROPATHY; NONHUMAN; OPTIC NEURITIS; RAT; RECURRENT DISEASE; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; VISUAL IMPAIRMENT; ANIMAL; ANTIBODY SPECIFICITY; BLOOD; CHILD; COHORT ANALYSIS; EPIDEMIOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOLOGY; MIDDLE AGED; MULTIPLE SCLEROSIS; RISK FACTOR;

ADOLESCENT; ADULT; ANIMALS; ANTIBODY SPECIFICITY; AUTOANTIBODIES; BIOLOGICAL MARKERS; CHILD; COHORT STUDIES; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; FRANCE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELITIS, TRANSVERSE; NEUROMYELITIS OPTICA; RATS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEROEPIDEMIOLOGIC STUDIES;

EID: 46749111830     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458507084595     Document Type: Article

References (19)

1. Devic E. Myelite subaiguë compliquée de névrite optique. Bull Med 1894; 8: 1033-4.
2. Gault F. De la neuromyélite optique aiguë. (thèse no891) Faculté de Médecine et de Pharmacie de Lyon, 1894.
3. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999; 53: 1107-14.
4. De Seze J, Lebrun C, Stojkovic T, Ferriby D, Hatel M, Vermersch P. Is Devic's neuromyelitis optica a separate disease? A comparative study with multiple sclerosis. Mult Scler 2003; 9: 521-5.
5. Jacob A, Boggild M. Neuromyelitis optica. J Neurol Neurosurg Psychiatry (compl) 2006; 6: 180-4.
6. Lucchinetti CF, Mandler RN, Mc Gavern D, Bruck W, Gleich G, Ransohof RM et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 2002; 125: 1450-61.
7. Wingerchuk DM. Neuromyelitis optica. Int MS J 2006; 13: 42-50.
8. Cree BA, Goodin DS, Hauser SL. Neuromyelitis optica. Semin Neurol 2002; 22: 105-22.
9. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004; 364: 2106-12.
10. Takahashi T, Fujihara K, Nakashima I, Misu T, Miyazawa I, Nakamura M et al. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain 2007; 130(Pt 5): 1235-43.
11. Hemmer B and Stüve O. Revised criteria for neuromyelitis optica-a new diagnostic standard? Nat Clin Pract Neurol(2007) 3: 132-3.
12. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121-7.
13. Rodriguez M, Siva A, Cross SA, O'Brien PC, Kurland LT. Optic neuritis: a population-based study in Olmsted county, Minnesota. Neurology 1995; 45: 244-50.
14. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory committee on clinical trials of new agents in multiple sclerosis. Neurology 1996; 46: 907-11.
15. Confavreux C, Vukusic S, Moreau T, Adeleine P. Relapses and progression of disability in multiple sclerosis. N Engl J Med 2000; 343: 1430-8.
16. Jarius S, Franciotta. D, Bergamaschi R, Wright H, Littleton E, Palace J et al. NMO-IgG in the diagnosis of neuromyelitis optica. Neurology 2007; 68(13): 1076-7.
17. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006; 66: 1485-9.
18. Ford B, Tampieri D, Francis G. Long-term follow-up of acute partial transverse myelopathy. Neurology 1992; 42: 250-2.
19. Weinshenker BG Wingerchuk DM, Vukusic S, Linbo L, Pittock SJ, Lucchinetti CF et al. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol 2006; 59: 566-9.